Our mission is to improve healthcare by developing novel catheter-based medical devices for minimally invasive delivery to the blood vessels in the brain, for the treatment of aneurysms, stroke, and other vascular defects. Aneuvas Technologies, Inc. (ATI), established in 2013 and headquartered in Flagstaff, Arizona, is a pioneering start-up dedicated to advancing healthcare. ATI specializes in developing innovative medical devices delivered with a catheter for minimally invasive treatment of brain aneurysms and strokes through precise delivery via the blood vessels. Currently, ATI holds four novel patents for devices that provide better biocompatibility and post-treatment outcomes of neurological defects.
